ID
21387
Beschrijving
NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: ABC-Containing Product Compliance Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV
Trefwoorden
Versies (1)
- 19-04-17 19-04-17 -
Geüploaded op
19 april 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Genetic Screening For HLA-B*5701 in Patients with HIV ABC-Containing Product Compliance NCT00340080
Genetic Screening For HLA-B*5701 ABC-Containing Product Compliance NCT00340080
Similar models
Genetic Screening For HLA-B*5701 ABC-Containing Product Compliance NCT00340080
C0013227 (UMLS CUI-2)
C0663655 (UMLS CUI-3)
C0947323 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
C0332156 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
C0947323 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
C0332156 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
C0947323 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
C0332156 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
C0039225 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])